title: Successful treatment with intravenous cyclophosphamide for anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis associated with myelodysplastic syndrome.
authors.affiliation: a Department of Medicine and Clinical Science, Division of Cardiology and Clinical Immunology , Yamaguchi University Graduate School of Medicine , Ube , Japan.
authors.forename: T
authors.initials: T
authors.lastname: Nawata
authors.affiliation: a Department of Medicine and Clinical Science, Division of Cardiology and Clinical Immunology , Yamaguchi University Graduate School of Medicine , Ube , Japan.
authors.forename: M
authors.initials: M
authors.lastname: Kubo
authors.affiliation: a Department of Medicine and Clinical Science, Division of Cardiology and Clinical Immunology , Yamaguchi University Graduate School of Medicine , Ube , Japan.
authors.forename: S
authors.initials: S
authors.lastname: Okuda
authors.affiliation: b Department of Neurology and Clinical Neuroscience , Yamaguchi University Graduate School of Medicine , Ube , Japan.
authors.forename: M
authors.initials: M
authors.lastname: Omoto
authors.affiliation: c Department of Medicine and Clinical Science, Division of Endocrinology, Metabolism, Hematological Science and Therapeutics , Yamaguchi University Graduate School of Medicine , Ube , Japan.
authors.forename: T
authors.initials: T
authors.lastname: Yujiri
authors.affiliation: b Department of Neurology and Clinical Neuroscience , Yamaguchi University Graduate School of Medicine , Ube , Japan.
authors.forename: T
authors.initials: T
authors.lastname: Kanda
authors.affiliation: a Department of Medicine and Clinical Science, Division of Cardiology and Clinical Immunology , Yamaguchi University Graduate School of Medicine , Ube , Japan.
authors.forename: M
authors.initials: M
authors.lastname: Yano
mesh_terms: D061605:Administration, Intravenous; D000328:Adult; D000906:Antibodies / Q000097:blood; D018501:Antirheumatic Agents / Q000008:administration & dosage; D001856:Bone Marrow Examination / Q000379:methods; D003520:Cyclophosphamide / Q000008:administration & dosage*; D003882:Dermatomyositis / Q000150:complications / Q000188:drug therapy / Q000276:immunology / Q000503:physiopathology; D006801:Humans; D000072640:Interferon-Induced Helicase, IFIH1 / Q000276:immunology*; D007564:Japan; D017563:Lung Diseases, Interstitial / Q000175:diagnosis / Q000209:etiology; D019028:Magnetic Resonance Imaging, Cine / Q000379:methods; D008297:Male; D018908:Muscle Weakness / Q000175:diagnosis / Q000209:etiology; D009190:Myelodysplastic Syndromes / Q000150:complications*; D012883:Skin Ulcer / Q000175:diagnosis / Q000209:etiology; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome; D018487:Ventricular Dysfunction, Left / Q000175:diagnosis / Q000209:etiology
chemical_list: D000906:Antibodies; D018501:Antirheumatic Agents; D003520:Cyclophosphamide; C452815:IFIH1 protein, human; D000072640:Interferon-Induced Helicase, IFIH1